AKHMADIEV, N.S.,
AKHMETOVA, V.R.,
IBRAGIMOV, A.G.,
GALIMOVA, A.M.,
GALIMOVA, R.A.,
AGLETDINOV, E.F.,
KATAEV, V.A.,
KHAIRULLINA, V.R. (2019) . The
tested compound is comparable, in terms of its activity to the hepatoprotective drug SAM according
KAZANTSEVA, A.V.,
DAVYDOVA, YU.D.,
ENIKEEVA, R.F.,
LOBASKOVA, M.M.,
MUSTAFIN, R.N.,
MALYKH, S.B.,
TAKHIROVA, Z.R.,
KHUSNUTDINOVA, E.K. (2020) ), and AVPR1B (rs33911258) genes, and gene-by-environment interactions were
tested with linear regression
Bogliolo, M.,
Catucci, I.,
Caleca, L.,
Lasheras, S.V.,
Pujol, R.,
Kiiski, J.I.,
Muranen, T.A.,
Barnes, D.R.,
Dennis, J.,
Michailidou, K.,
Bolla, M.K.,
Leslie, G.,
Figlioli, G. (2019) , with greater effects for the ER-negative and triple-negative breast cancer (TNBC) subtypes. We
tested the three
Idrisov, Bulat,
Lunze, Karsten,
Cheng, Debbie M.,
Elena Blokhina,
Gnatienko, Natalia,
Quinn, Emily,
Bridden, Carly,
Walley, Alexander Y.,
Bryant, Kendall J.,
Lioznov, Dmitry,
Krupitsky, Evgeny,
Samet, Jefrey H. (2017) ) and serum
tests (HVL). To examine the primary outcome, we used multiple logistic regression models
Ye, L.,
Chen, X.,
Wang, M.,
Jin, L.,
Zhuang, Z.,
Yang, D.,
Guan, X.,
Samorodov, A.V.,
Pavlov, V.N.,
Chattipakorn, N.,
Feng, J.,
Wang, Y.,
Luo, W.,
Liang, G. (2021) targeting JNK. In the present study, we have
tested the hypothesis that C66 could prevent obesity
Dorling, L.,
Carvalho, S.,
Allen, J.,
González-Neira, A.,
Luccarini, C.,
Wahlström, C.,
Pooley, K.A.,
Parsons, M.T.,
Fortuno, C.,
Wang, Q.,
Bolla, M.K.,
Dennis, J.,
Bermisheva, M.,
Khusnutdinova, E.,
Prokofyeva, D.,
other additional authors (2021) BACKGROUND Genetic
testing for breast cancer susceptibility is widely used, but for many genes
Boykо, A.,
Fernández, O.,
Alifirova, V.,
Babicheva, N.,
Bakhtiyarova, K.,
Volkov, A.,
Glavinskaya, N.,
Goncharova, Z.,
Greshnova, I.,
Smagina, I.,
Lashch, N.,
Inzhinova, A. (2021) the Russian Federation would have
tested for antibodies to disorders of the optical spectrum of neuromyelitis
Boyko, A.N.,
Bakhtiyarova, K.Z.,
Brylev, L.V.,
Zakharova, M.N.,
Kasatkin, D.S.,
Korobko, D.S.,
Kotov, S.V.,
Krasnov, V.S.,
Malkova, N.A.,
Popova, E.V.,
Sivertseva, S.A.,
Simaniv, T.O.,
Sokolova, A.A.,
Totolyan, N.A.,
Trushnikova, T.N.,
Khabirov, F.A.,
Khachanova, N.V. (2021) diagnostic program including the aquaporin-4 antibodies (AQP4-IgG)
testing; to evaluate the implementation
Korytina, GF,
Akhmadishina, LZ,
Kochetova, OV,
Nasibullin, TR,
Aznabaeva, YG,
Zulkarneev, SR,
Izmailova, SM,
Zagidullin, SZ,
Victorova, TV (2021) of the respiratory system. Smoking is a major risk factor of COPD. Neurotransmitter system genes were
tested